SEK 0.87
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -44.97 Million SEK | -71.86% |
2022 | -7.58 Million SEK | -13.62% |
2021 | -58.56 Million SEK | 93.59% |
2020 | -204.68 Million SEK | -42.24% |
2019 | -69.62 Million SEK | -81.05% |
2018 | -37.81 Million SEK | -32.47% |
2017 | -29.62 Million SEK | -22.42% |
2016 | -24.08 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3.01 Million SEK | 34.3% |
2024 Q2 | -1.89 Million SEK | 35.35% |
2023 FY | - SEK | -71.86% |
2023 Q2 | -2.94 Million SEK | -109.55% |
2023 Q3 | -3.55 Million SEK | -20.65% |
2023 Q4 | -36.94 Million SEK | -939.68% |
2023 Q1 | 30.84 Million SEK | 820.27% |
2022 Q2 | -12.19 Million SEK | 3.84% |
2022 FY | - SEK | -13.62% |
2022 Q4 | -4.28 Million SEK | 50.44% |
2022 Q3 | -8.64 Million SEK | 29.11% |
2022 Q1 | -12.67 Million SEK | 10.37% |
2021 Q4 | -14.14 Million SEK | 7.63% |
2021 FY | - SEK | 93.59% |
2021 Q3 | -15.31 Million SEK | 0.0% |
2020 FY | - SEK | -42.24% |
2019 FY | - SEK | -81.05% |
2018 FY | - SEK | -32.47% |
2017 FY | - SEK | -22.42% |
2016 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
BrainCool AB (publ) | -58.68 Million SEK | 23.36% |
Neola Medical AB (publ) | -7.57 Million SEK | -493.599% |